Literature DB >> 16365807

Bacterial endophthalmitis after triamcinolone acetonide-assisted pars plana vitrectomy.

Yoshinori Mitamura1, Nagako Miyano2, Kenji Ohtsuka2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16365807     DOI: 10.1007/s10384-005-0250-8

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


× No keyword cloud information.
  5 in total

1.  Triamcinolone acetonide as an aid to visualization of the vitreous and the posterior hyaloid during pars plana vitrectomy.

Authors:  G A Peyman; R Cheema; M D Conway; T Fang
Journal:  Retina       Date:  2000       Impact factor: 4.256

2.  Endophthalmitis in eyes following vitrectomy.

Authors:  T Sharma; L Gopal; L Therese
Journal:  Ophthalmic Surg Lasers       Date:  1998-10

3.  Infectious and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injection.

Authors:  Mark L Nelson; Matthew T S Tennant; Arunan Sivalingam; Carl D Regillo; Jonathan B Belmont; Adam Martidis
Journal:  Retina       Date:  2003-10       Impact factor: 4.256

4.  Incidence of acute endophthalmitis after triamcinolone-assisted pars plana vitrectomy.

Authors:  Taiji Sakamoto; Hiroshi Enaida; Toshiaki Kubota; Masaaki Nakahara; Keita Yamakiri; Takehiro Yamashita; Mitsunobu Yokoyama; Yasuaki Hata; Toshinori Murata; Kazunori Miyata; Akinori Uemura; Wataru Kimura; Tatsuro Ishibashi
Journal:  Am J Ophthalmol       Date:  2004-07       Impact factor: 5.258

5.  Weak symptoms of bacterial endophthalmitis after a triamcinolone acetonide-assisted pars plana vitrectomy.

Authors:  Takehiro Yamashita; Norihito Doi; Taiji Sakamoto
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-06-29       Impact factor: 3.117

  5 in total
  1 in total

1.  A case of mycotic endophthalmitis after triamcinolone acetonide-assisted pars plana vitrectomy.

Authors:  Shinsuke Ataka; Kaori Kurita; Sonomi Wada; Kohno Tayeya; Kunihiko Shiraki
Journal:  Int Ophthalmol       Date:  2007-03-29       Impact factor: 2.031

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.